Technologies to deliver
We are one of the few companies globally that have developed dry powder inhalers (DPI), pressurised metered dose inhalers (pMDI) and nebulisers to deliver a broad range of complex inhaled therapies
With our formulation and device technology, combined with product development expertise, we have helped customers and partners bring 11 inhaled medicines to market.
Corporate and investor news
Hikma submits response to FDA for our joint generic Advair Diskus® programme
Read more